OpenAlex
PricingAboutJobs
Log inGet started
Author

Rui-Feng Xu

Institution: Abbisko Therapeutics Co., Ltd. (China)
Observed institution: Abbisko Therapeutics Co., Ltd. (China)
ORCID: 0009-0003-1724-7085
Observed ORCID: 0009-0003-1724-7085
OpenAlex ID: A5113060388
EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023 · Bin Shen, Jue-Ping Shi, et al. · Molecular Cancer Therapeutics · 15
Data from EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023 · Bin Shen, Jue-Ping Shi, et al.
Data from EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023 · Bin Shen, Jue-Ping Shi, et al.
Supplementary Data from EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023 · Bin Shen, Jue-Ping Shi, et al.
PDF
Works count: 4
Citation count: 15
H-index: 1
I10-index: 1
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms